Results from Phase 3 trials for non-infectious uveitis treatment ➤ FDA allows new gene therapy for Leber congenital amaurosis to begin clinical testing ➤ FDA approves OTC drop for redness ➤ Company ne ...

“You can’t really know where you are going until you know where you have been.” This adage applies to a paper recently published in the Journal of Cataract & Refractive Surgery (JCRS), adding to the ...

SpyGlass Pharma announced positive 4-year, first-in-human results (n=21) with its Bimatoprost Drug Pad-IOL System (BIM-IOL System) for patients with mild to moderate open angle glaucoma or ocular ...

Glaukos presented positive topline results from its Phase 3 extension study, which followed for 3 years a cohort of patients with keratoconus who received epithelium-on crosslinking with Epioxa ...

Being successful in ophthalmology goes beyond just providing excellent clinical care, and learning and teaching has a ...

The John A. Moran Eye Center ophthalmology residents reviewed “Long-term outcomes of corneal crosslinking for keratoconus ...

The John A. Moran Eye Center ophthalmology residents reviewed “Long-term outcomes of corneal crosslinking for keratoconus across pediatric, adolescent, and adult populations in a diverse U.S.

Discussing the device further in a Q&A, Dr. Mah noted that the EndoArt has been well received in Europe. Once you start getting used to it, the indications start expanding if you get good results and ...

Karl Deisseroth, MD, PhD, Peter Hegemann, PhD, and Georg Nagel, PhD, were awarded the Nobel Prize in Physiology or Medicine “for their discoveries concerning light-gated ion channels and optogenetics.

Refractive cataract surgery continues to advance on the techniques and technologies we use to improve visual quality in our patients. This is particularly evident when discussing IOL technologies, ...